359 related articles for article (PubMed ID: 15229304)
1. A randomized trial of multivitamin supplements and HIV disease progression and mortality.
Fawzi WW; Msamanga GI; Spiegelman D; Wei R; Kapiga S; Villamor E; Mwakagile D; Mugusi F; Hertzmark E; Essex M; Hunter DJ
N Engl J Med; 2004 Jul; 351(1):23-32. PubMed ID: 15229304
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
Mehta S; Fawzi W
Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania.
Fawzi WW; Msamanga GI; Spiegelman D; Urassa EJ; McGrath N; Mwakagile D; Antelman G; Mbise R; Herrera G; Kapiga S; Willett W; Hunter DJ
Lancet; 1998 May; 351(9114):1477-82. PubMed ID: 9605804
[TBL] [Abstract][Full Text] [Related]
4. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
5. Effects of maternal vitamin supplements on malaria in children born to HIV-infected women.
Villamor E; Msamanga G; Saathoff E; Fataki M; Manji K; Fawzi WW
Am J Trop Med Hyg; 2007 Jun; 76(6):1066-71. PubMed ID: 17556612
[TBL] [Abstract][Full Text] [Related]
6. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.
Austin J; Singhal N; Voigt R; Smaill F; Gill MJ; Walmsley S; Salit I; Gilmour J; Schlech WF; Choudhri S; Rachlis A; Cohen J; Trottier S; Toma E; Phillips P; Ford PM; Woods R; Singer J; Zarowny DP; Cameron DW;
Eur J Clin Nutr; 2006 Nov; 60(11):1266-76. PubMed ID: 16721396
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants.
Baylin A; Villamor E; Rifai N; Msamanga G; Fawzi WW
Eur J Clin Nutr; 2005 Aug; 59(8):960-8. PubMed ID: 15956998
[TBL] [Abstract][Full Text] [Related]
8. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
[TBL] [Abstract][Full Text] [Related]
9. Vitamins in HIV disease progression and vertical transmission.
Fawzi WW; Hunter DJ
Epidemiology; 1998 Jul; 9(4):457-66. PubMed ID: 9647913
[TBL] [Abstract][Full Text] [Related]
10. Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation.
Fawzi W; Msamanga G; Antelman G; Xu C; Hertzmark E; Spiegelman D; Hunter D; Anderson D
Clin Infect Dis; 2004 Mar; 38(5):716-22. PubMed ID: 14986257
[TBL] [Abstract][Full Text] [Related]
11. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania.
Fawzi WW; Msamanga G; Hunter D; Urassa E; Renjifo B; Mwakagile D; Hertzmark E; Coley J; Garland M; Kapiga S; Antelman G; Essex M; Spiegelman D
J Acquir Immune Defic Syndr; 2000 Mar; 23(3):246-54. PubMed ID: 10839660
[TBL] [Abstract][Full Text] [Related]
15. Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania.
Fawzi WW; Msamanga GI; Kupka R; Spiegelman D; Villamor E; Mugusi F; Wei R; Hunter D
Am J Clin Nutr; 2007 May; 85(5):1335-43. PubMed ID: 17490971
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the Tanzania Vitamin and HIV Infection Trial.
Fawzi WW; Msamanga GI; Spiegelman D; Urassa EJ; Hunter DJ
Control Clin Trials; 1999 Feb; 20(1):75-90. PubMed ID: 10027501
[TBL] [Abstract][Full Text] [Related]
19. Predictors of incident tuberculosis among HIV-1-infected women in Tanzania.
Venkatesh PA; Bosch RJ; McIntosh K; Mugusi F; Msamanga G; Fawzi WW
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1105-11. PubMed ID: 16229221
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
